表紙
市場調查報告書

全球冷凍乾燥製劑市場:藥物類別,適應症,包裝類型,各地區 - 規模,佔有率,趨勢,及預測

Lyophilized Drugs Market, by Drug Class, by Indication, by Packaging Type, and by region - Size, Share, Trends, and Forecast 2018 - 2026

出版商 Coherent Market Insights 商品編碼 906229
出版日期 內容資訊 英文 208 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球冷凍乾燥製劑市場:藥物類別,適應症,包裝類型,各地區 - 規模,佔有率,趨勢,及預測 Lyophilized Drugs Market, by Drug Class, by Indication, by Packaging Type, and by region - Size, Share, Trends, and Forecast 2018 - 2026
出版日期: 2019年07月29日內容資訊: 英文 208 Pages
簡介

本報告提供全球冷凍乾燥製劑市場的相關調查,提供主要的開發和趨勢,市場機會,藥物類別·適應症·包裝·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查的目的及假設

  • 調查目的
  • 假設
  • 簡稱

第2章 市場概要

  • 報告的說明
    • 市場定義及範圍
  • 摘要整理
    • 各類藥物
    • 各適應症
    • 各包裝
    • 各地區
  • COM (Coherent Opportunity Map)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的開發
  • 技術的進步
  • 歷史概要
  • 合併及收購
  • 法規方案
  • 波特的五力分析
  • PEST分析

第4章 冷凍乾燥製劑的全球市場:各類藥物

  • 簡介
  • 抗感染藥
  • 抗癌藥物
  • 利尿劑
  • 質子幫浦抑制劑
  • 麻醉劑
  • 抗凝固劑
  • NSAID
  • 其他

第5章 冷凍乾燥製劑的全球市場:各適應症

  • 簡介
  • 感染疾病
  • 自體免疫疾病
  • 腸胃疾病
  • 癌症
  • 其他

第6章 冷凍乾燥製劑的全球市場:各包裝

  • 簡介
  • 管瓶
  • 注射器
  • 濾芯

第7章 冷凍乾燥製劑的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第8章 競爭情形

  • 熱圖分析
  • 企業簡介
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Fresenius Kabi USA, LLC.
    • Ciron Drugs & Pharmaceuticals Pvt Ltd.
    • GlaxoSmithKline plc.
    • Mylan NV.
    • Pfizer, Inc.
    • Amneal Pharmaceuticals LLC
    • 大塚集團株式會社 (大塚製藥株式會社)
    • BTG Plc.
  • 分析師的見解

第9章 章節

  • 參照資料
  • 調查方法
  • 關於Coherent Market Insight
目錄

Title:
Lyophilized Drugs Market, by Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton Pump Inhibitor, Anesthetic, Anticoagulant, NSAID's, and Others), by Indication (Infectious Disease, Autoimmune Disease, Gastrointestinal Disease, Cancer, and Others), by Packaging Type (Vial, Injection, and Cartridge), and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026.

Lyophilization or freeze drying is the process, in which the water content in the drug sample is frozen, followed by its removal from the sample. In the process of lyophilization, the frozen water content changes directly from solid to vapor without passing through a liquid phase. The process includes three steps: Freezing, primary drying (sublimation), and secondary drying (desorption). Pharmaceutical products that undergo lyophilization process include bulk pharmaceutical/biopharmaceutical ingredient (API), protein, collagen, peptide, oligonucleotide, enzymes, and mAbs.

Market Dynamics:

Lyophilized drugs are majorly used to treat infectious diseases and autoimmune diseases. Thus, increasing prevalence of infectious diseases is expected to aid in growth of the global lyophilized drugs market. For instance, according to The Lancet Infectious Diseases (report) published in 2017, fungal infection affects over a billion people worldwide, resulting in around 11.5 million life-threatening infections and over 1.5 million deaths, annually. The number of lyophilized drugs such as Amphotericin B (Mycoflu), Vonfung NDD (voriconazole,) and other antifungal lyophilized drugs are available in market for treating fungal infections.

Lyophilized drug manufacturers are looking forward to expand their facilities to produce lyophilized drugs on large scale, which in turn contributing to growth of the global lyophilized drugs market. For instance, on January 2017, AB Technologies (AB) announced investment of US$ 10.5 million to build a new 23,000-square-foot manufacturing facility at its site in Bloomington, Indiana. The new facility will include manufacturing area for formulating, filling, lyophilizing, and packaging drugs for early-phase clinical trial studies. Moreover, AB Technologies (AB) added aseptic filling and lyophilizer loading systems into the new facility.

Major pharmaceutical manufacturers are engaged in the development and launching of innovative lyophilized drugs, which is expected to drive the global lyophilized drugs market growth. For instance, in November 2018, Xellia Pharmaceuticals launched Vancomycin Hydrochloride for Injection, USP within the U.S. market. Vancomycin Hydrochloride for Injection is lyophilized powder to treat or prevent infections that are caused by bacteria

Key features of the study:

  • This report provides in-depth analysis of the global lyophilized drugs market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2018-2026), considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global lyophilized drugs market based on the following parameters - company overview, financial performance, Technology portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Sanofi S.A, Merck & Co., Inc., Fresenius Kabi USA, LLC., Ciron Drugs & Pharmaceuticals Pvt Ltd., GlaxoSmithKline plc., Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.), and BTG Plc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future technology launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global lyophilized drugs market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global Lyophilized Drugs Market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Lyophilized Drugs Market, By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
  • Global Lyophilized Drugs Market, By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
  • Global Lyophilized Drugs Market, By Packaging Type:
    • Vial
    • Injection
    • Cartridge
  • Global Lyophilized Drugs Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Middle East
      • By Country/Region:
    • GCC
    • Israel
    • Rest of Middle East
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Drug Class:
    • Anti-infective
    • Antineoplastic
    • Diuretics
    • Proton Pump Inhibitor
    • Anesthetic
    • Anticoagulant
    • NSAID's
    • Others
      • By Indication:
    • Infectious Disease
    • Autoimmune Disease
    • Gastrointestinal Disease
    • Cancer
    • Others
      • By Packaging Type:
    • Vial
    • Injection
    • Cartridge
  • Company Profiles
    • Sanofi S.A *
      • Company Overview
      • Technology Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Merck & Co., Inc.
    • Fresenius Kabi USA, LLC.
    • Ciron Drugs & Pharmaceuticals Pvt Ltd.
    • GlaxoSmithKline plc.
    • Mylan NV.
    • Pfizer, Inc.
    • Amneal Pharmaceuticals LLC
    • Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
    • BTG Plc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Indication
    • Market Snippet, By Packaging Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technology Advancements
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Lyophilized Drugs Market, By Drug Class, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Anti-infective
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Antineoplastic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Diuretics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Proton Pump Inhibitor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Anesthetic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Anticoagulant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • NSAID's
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Lyophilized Drugs Market, By Indication, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Infectious Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Autoimmune Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Gastrointestinal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Lyophilized Drugs Market, By Packaging Type, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Vials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Cartridge
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Lyophilized Drugs Market, By Region, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Drug Class, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Drug Class, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Class, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Drug Class, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • Market Size and Forecast, By Drug Class, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Class, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Indication, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Packaging Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Sanofi S.A.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Fresenius Kabi USA, LLC.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Ciron Drugs & Pharmaceuticals Pvt Ltd.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Mylan NV.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pfizer, Inc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Amneal Pharmaceuticals LLC
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BTG Plc.
    • Company Overview
    • Technology Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top